MREO · Mereo BioPharma Group plc · Investor Relations
Market Cap
$47.12M
Shares
159.69M
Volume · Oct 21
288.32K
Avg daily vol (3M)
4M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-07 | Mereo BioPharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference 2026 | Conference |
| 2026-08-11 | Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights | Results publication |
| 2026-08-11 | Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) | Event |
| 2026-06-02 | Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference 2026 | Conference |
| 2026-05-12 | Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates | Results publication |
| 2026-03-19 | Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights | Results publication |